{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"producer": "iLovePDF", "creator": "PDFMiner", "creationdate": "", "moddate": "2025-09-14T06:45:35+00:00", "total_pages": 280, "source": "/home/thiru/draft-oasis-e1-manual-04-28-2024_edited.pdf"}, "page_content": "Coding Tips \n\n\u2022  The drug regimen review is part of the comprehensive patient assessment. The comprehensive patient \n\nassessment is the responsibility of and must ultimately be completed by one clinician, but collaboration is \nallowed. Agency policy and practice will determine this process and how it is documented. \no  For example, for this drug regimen review item, collaboration in which the assessing clinician evaluates \npatient status (for example, presence of potential ineffective drug therapy or patient nonadherence), and \nanother clinician (in the office) assists with review of the medication list (for example, possible duplicate \ndrug therapy or omissions) is allowed. \n\n\u2022 \n\nIf portions of the drug regimen review (for example, identification of potential drug-drug interactions or \npotential dosage errors) are completed by agency staff other than the clinician responsible for completing the \nSOC/ROC OASIS, information on drug regimen review findings must be communicated to the assessing \nclinician responsible for the SOC/ROC OASIS assessment so that the appropriate response for M2001 may be \nentered. \no  The M0090 Date Assessment Completed, is the last date that information used to complete the \n\ncomprehensive assessment and determine OASIS coding was gathered by the assessing clinician and \ndocumentation of the specific information/responses was completed. \n\nOASIS-E1 \nEffective 01/01/2025 \nCenters for Medicare & Medicaid Services \n\n214\n\fChapter 3 \n\nExamples \n\nSection N: Medications \n\n1.  No issues identified, During the comprehensive assessment visit, the PT reviews all the patient\u2019s", "type": "Document"}}